Competing interests
C.H.
A.G., V.C., A.D., S.A., R.K., K.S., A.M., C.K., B.E., V.M., E.K., K.S., E.K., R.B., D.C., X.Z., V.S., C.H., N.M., A.S. and J.A.G. are Kymera Therapeutics employees and may have stock or stock options. J.D. and H.R. are former Kymera Therapeutics employees and may have stock or stock options. J.C. is a full-time consultant working for Kymera Therapeutics. All other authors (L.A., G.A., S.B., H.S., B.J.F., P.L. and A.A.) are employees of their respective companies; they were investigators from clinical sites in the trial and received payment for their participation in the trial.